WALTHAM,
Mass., Jan. 20, 2023 /PRNewswire/ -- Fresenius
Medical Care (FME), the world's leading provider of products and
services for individuals with renal diseases, has taken the Zero
Health Gaps Pledge at the World Economic Forum in Davos, Switzerland.
The Zero Health Gaps Pledge is part of the Global Health Equity
Network (GHEN), which brings together key stakeholders from the
public and private sectors to advance a collective vision of Zero
Health Gaps, in line with the UN Sustainable Development Goals. In
total, 36 companies from eight countries committed to sign the
first-in-kind global pledge. By taking the pledge, Fresenius
Medical Care is declaring its commitment to meaningful action and
collaboration toward health equity.
"We believe that access to equitable and high-quality health
care is a fundamental human right, and we are committed to working
with global leaders and organizations to improve the lives of
millions of people throughout the world," said Helen Giza, CEO of Fresenius Medical Care. "We
will also look inward and achieve clear, actionable steps to make
our processes economically and environmentally sustainable, while
increasing access to the care we provide in the global communities
we serve."
The difference in average life expectancy at birth between high-
and low-income countries is glaring at 78 and 64 years
respectively. Global climate and health crises, including the
COVID-19 pandemic, have heightened both the severity of these
inequities and the potential consequences of inaction. The Zero
Health Gaps Pledge is a direct response to the growing health
disparities across the globe.
Fresenius Medical Care has taken a number of actions to address
health equity. The company's Health Equity Dashboard provides
important demographic and regional data to identify possible
inequities in key patient outcomes. The goal is to tailor
interventions to individuals in different locations to help ensure
there are no care delivery gaps.
"Around 3.8 million patients worldwide regularly undergo
dialysis treatment. Fresenius Medical Care is passionate about the
importance of closing the gaps in health equity," said Franklin W. Maddux, MD, Global Chief Medical
Officer. "We are excited to help lead the way for the international
health care community by taking the Zero Health Gaps Pledge and
look forward to tackling this significant challenge head on."
Nwamaka (Amaka) Eneanya, MD, Head
of Strategy and Operations for the Global Medical Office, will lead
the company's global health equity strategy including its efforts
to meet the Zero Health Gaps Pledge. She will work with
Mignon Early, Vice President of
Diversity, Equity, and Inclusion, to ensure strategic initiatives
are developed in the context of Fresenius Medical Care's diverse
employee base.
Click here to read the complete "Zero Health Gaps Pledge"
including its ten key commitments, and click here to learn more
about the Global Health Equity Network.
Fresenius Medical Care is the world's leading provider of
products and services for individuals with renal diseases of which
around 3.8 million patients worldwide regularly undergo dialysis
treatment. Through its network of 4,153 dialysis clinics, Fresenius
Medical Care provides dialysis treatments for approximately 345,000
patients around the globe. Fresenius Medical Care is also the
leading provider of dialysis products such as dialysis machines or
dialyzers. Along with its core business, the Renal Care Continuum,
the Company focuses on expanding in complementary areas and in the
field of critical care. Fresenius Medical Care is listed on the
Frankfurt Stock Exchange (FME) and on the New York Stock Exchange
(FMS).
For more information visit the Company's website at
www.freseniusmedicalcare.com.
Disclaimer:
This release contains forward-looking statements that are subject
to various risks and uncertainties. Actual results could differ
materially from those described in these forward-looking statements
due to various factors, including, but not limited to, changes in
business, economic and competitive conditions, legal changes,
regulatory approvals, impacts related to the COVID-19 pandemic
results of clinical studies, foreign exchange rate fluctuations,
uncertainties in litigation or investigative proceedings, and the
availability of financing. These and other risks and uncertainties
are detailed in Fresenius Medical Care AG & Co. KGaA's reports
filed with the U.S. Securities and Exchange Commission. Fresenius
Medical Care AG & Co. KGaA does not undertake any
responsibility to update the forward-looking statements in this
release.
Media contact
Martin
Kunze
T +49 6172 608-2115
martin.kunze@fresenius.com
Media contact (North
America)
Christopher
Loh
christopher.loh@freseniusmedicalcare.com
Contact for analysts and investors
Dr. Dominik Heger
T +49 6172 609-2601
dominik.heger@fmc-ag.com
www.freseniusmedicalcare.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/fresenius-medical-care-takes-action-to-close-global-health-gaps-signs-zero-health-gaps-pledge-at-the-world-economic-forum-301726358.html
SOURCE Fresenius Medical Care Holdings, Inc.